B.S. University of Delaware
Kelly’s research interests are in developing and evaluating novel gene editing strategies in non-small cell lung carcinoma in order to synergistically increase chemosensitivity in a cancer-specific manner. Her current focus is on targeting cancer-specific NRF2 mutations with CRISPR gene editing tools, and evaluating the short and long-term effects these specific targeting strategies have on the cell cycle and metabolism of affected and neighboring cells. She received her B.S. from the University of Delaware in 2017, while working with the group as an undergraduate research assistant, and is currently pursuing her Ph.D.